| Accession | SAMC2957525 |
|---|---|
| Accession in Other Database | GSA-Human: HRS893462 |
| Sample name | H200536 |
| Title | H200536 |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | plasma sample from bladder patient |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA005063 in the GSA-Human system. |
| Release date | 2024-01-01 |
| BioProject Accession | PRJCA018203 |
| Submitter | Jingyu Zang (rjbladder@163.com) |
| Organization | Shanghai Jiao Tong University School of Medicine |
| Submission date | 2023-07-26 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA005063 (Controlled Access) | Bladder preservation is a viable option for some muscle-invasive bladder cancer (MIBC) patients, but an effective noninvasive biomarker test to accurately identify promising candidates is lacking. Here we present the clinical application of a novel tissue-agnostic, urine-based minimal residual disease (MRD) assay in the neoadjuvant setting for personalized disease surveillance and actionable target identification to facilitate bladder-sparing treatment approaches. |